Imunon (IMNN) Net Cash Flow (2010 - 2026)
Imunon's (IMNN) quarterly Net Cash Flow came in at -$4.0 million in Q1 2026, down 32.85% YoY from -$5.9 million in Q1 2025, and down 212.94% on a QoQ basis from $3.5 million in Q4 2025.
Imunon (IMNN) Net Cash Flow (2010 - 2026) Analysis & Trends
Imunon (IMNN) has 17 years of Net Cash Flow data on file, last reported at -$4.0 million in Q1 2026.
- Quarterly Net Cash Flow fell 32.85% year-over-year to -$4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 122.51% YoY) and the FY2025 annual result came in at $2.9 million, up 8403.53% from the prior year.
- Net Cash Flow slipped to -$4.0 million in Q1 2026, from $3.5 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $8.8 million in Q1 2022 to a low of -$15.4 million in Q4 2022.
- A 5-year average of -$2.1 million and a median of -$3.0 million in 2025 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow surged 3101.05% — and 2024, when it tumbled 219.73%.
- Tracing IMNN's Net Cash Flow over 5 years: stood at -$15.4 million in 2022, then surged by 54.38% to -$7.0 million in 2023, then soared by 36.99% to -$4.4 million in 2024, then jumped by 179.52% to $3.5 million in 2025, then tumbled by 212.94% to -$4.0 million in 2026.
- The last three Net Cash Flow figures came in at -$4.0 million (Q1 2026), $3.5 million (Q4 2025), and $522153.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 225.59 Mn |
| 10 | Imunon | 8.50 Mn | 8.50 Mn | - | 7.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.15 Mn |
| Jun 30, 2026 | 7.15 Mn |
| Mar 31, 2026 | -3.99 Mn |
| Mar 31, 2026 | -3.99 Mn |
| Dec 31, 2025 | 3.53 Mn |
| Dec 31, 2025 | 3.53 Mn |
| Sep 30, 2025 | 522,153.00 |
| Sep 30, 2025 | 522,153.00 |
| Jun 30, 2025 | 1.86 Mn |
| Jun 30, 2025 | 1.86 Mn |
| Mar 31, 2025 | -3.00 Mn |
| Mar 31, 2025 | -3.00 Mn |
| Dec 31, 2024 | -4.44 Mn |
| Dec 31, 2024 | -4.44 Mn |
| Sep 30, 2024 | -4.06 Mn |
| Sep 30, 2024 | -4.06 Mn |
| Jun 30, 2024 | 2.96 Mn |
| Jun 30, 2024 | 2.96 Mn |
| Mar 31, 2024 | -3.49 Mn |
| Mar 31, 2024 | -3.49 Mn |